IFITM2 and infection: Similarly, infection of these cells with PLVs and replication-competent SARS-CoV-2 at an MOI of 0.005 revealed that infection was not inhibited but rather was enhanced by the presence of IFITM2-Y19F (Fig. 2G and H).